Ditchcarbon
  • Contact
  1. Organizations
  2. Ocular Therapeutix, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 13 days ago

Ocular Therapeutix, Inc.

Company website

Ocular Therapeutix, Inc., commonly referred to as Ocular Therapeutix, is a pioneering biopharmaceutical company headquartered in the United States. Founded in 2014, the company focuses on the development and commercialisation of innovative therapies for ocular diseases and conditions. With a strong presence in the ophthalmic industry, Ocular Therapeutix has made significant strides in creating unique drug delivery systems that enhance patient outcomes. The company’s flagship products include Dextenza, a sustained-release dexamethasone insert for post-surgical inflammation, and OTX-TP, a novel treatment for glaucoma. These offerings distinguish Ocular Therapeutix in the market, showcasing its commitment to advancing ocular health. Recognised for its innovative approach, Ocular Therapeutix continues to solidify its position as a leader in the ophthalmic therapeutics sector, driving forward with a robust pipeline of products aimed at addressing unmet medical needs.

DitchCarbon Score

How does Ocular Therapeutix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Ocular Therapeutix, Inc.'s score of 25 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

43%

Let us know if this data was useful to you

Ocular Therapeutix, Inc.'s reported carbon emissions

Ocular Therapeutix, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Ocular Therapeutix may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the company does not inherit emissions data from a parent organisation, it operates independently regarding its climate impact reporting. Without specific emissions figures or reduction initiatives, Ocular Therapeutix's climate commitments remain unclear within the broader context of industry standards for sustainability and carbon management.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ocular Therapeutix, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ocular Therapeutix, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ocular Therapeutix, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Omeros Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Harrow, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

IVERIC bio, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Santen Pharmaceutical

JP
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Diplomat Pharmacy, Inc.

US
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 18 days ago

Neoleukin Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251001.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy